You are viewing an incomplete version of our website. Please click to reload the website as full version.

beta-Site APP-Cleaving Enzyme 2 (BACE2) (N-Term) Peptide

Details for Product No. ABIN1382051, Supplier: Log in to see
Protein Name
  • 1110059C24Rik
  • AI850424
  • ALP56
  • ARP1
  • ASP1
  • ASP21
  • BAE2
  • CDA13
  • CEAP1
  • DRAP
Protein Region
Blocking Peptide (BP)
Log in to see
Supplier Product No.
Log in to see

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-beta-Site APP-Cleaving Enzyme 2 (BACE2) (N-Term) antibody (ABIN1031256)
Characteristics 16 amino amino terminus of human BACE2.
Research Area Proteolysis / Ubiquitin, Alzheimer's Disease, Enzymes
Application Notes BACE2 peptide is used for blocking the. activity of BACE2.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications Yan, Bienkowski, Shuck et al.: "Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity." in: Nature, Vol. 402, Issue 6761, pp. 533-7, 1999 (PubMed).

Kobayashi, Hatano, Otaki et al.: "Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, Issue 4, pp. 1457-62, 1999 (PubMed).